383 related articles for article (PubMed ID: 27553864)
1. The epidemiology of metastases in neuroendocrine tumors.
Riihimäki M; Hemminki A; Sundquist K; Sundquist J; Hemminki K
Int J Cancer; 2016 Dec; 139(12):2679-2686. PubMed ID: 27553864
[TBL] [Abstract][Full Text] [Related]
2. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study.
Cai W; Tan Y; Ge W; Ding K; Hu H
Cancer Med; 2018 Jun; 7(6):2699-2709. PubMed ID: 29733523
[TBL] [Abstract][Full Text] [Related]
3. Metastatic sites and survival in lung cancer.
Riihimäki M; Hemminki A; Fallah M; Thomsen H; Sundquist K; Sundquist J; Hemminki K
Lung Cancer; 2014 Oct; 86(1):78-84. PubMed ID: 25130083
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.
Yang Z; Klimstra DS; Hruban RH; Tang LH
Am J Surg Pathol; 2017 Jul; 41(7):915-922. PubMed ID: 28498280
[TBL] [Abstract][Full Text] [Related]
5. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.
Hallet J; Law CH; Cukier M; Saskin R; Liu N; Singh S
Cancer; 2015 Feb; 121(4):589-97. PubMed ID: 25312765
[TBL] [Abstract][Full Text] [Related]
6. Metastatic spread in patients with gastric cancer.
Riihimäki M; Hemminki A; Sundquist K; Sundquist J; Hemminki K
Oncotarget; 2016 Aug; 7(32):52307-52316. PubMed ID: 27447571
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: A single-center study.
Song L; Zhai X; Yu S; Ma Y; Wang F; Yu X; Tao S; Lian Y; Yang M; Tao W; Fan Q
Cancer Med; 2019 Jul; 8(8):3729-3737. PubMed ID: 31127690
[TBL] [Abstract][Full Text] [Related]
8. Fine needle aspiration cytology of hepatic metastases of neuroendocrine tumors: A 20-year retrospective, single institutional study.
Saeed OAM; Cramer H; Wang X; Wu HH
Diagn Cytopathol; 2018 Jan; 46(1):35-39. PubMed ID: 29076658
[TBL] [Abstract][Full Text] [Related]
9. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype.
Hsu C; Rashid A; Xing Y; Chiang YJ; Chagpar RB; Fournier KF; Chang GJ; You YN; Feig BW; Cormier JN
J Surg Oncol; 2013 Feb; 107(2):136-43. PubMed ID: 22767417
[TBL] [Abstract][Full Text] [Related]
10. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.
Kim MK; Warner RR; Ward SC; Harpaz N; Roayaie S; Schwartz ME; Itzkowitz S; Wisnivesky J
Neuroendocrinology; 2015; 101(1):58-65. PubMed ID: 25572143
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological analysis in patients with neuroendocrine tumors that metastasized to the brain.
Akimoto J; Fukuhara H; Suda T; Nagai K; Ichikawa M; Fukami S; Kohno M; Matsubayashi J; Nagao T
BMC Cancer; 2016 Jan; 16():36. PubMed ID: 26801624
[TBL] [Abstract][Full Text] [Related]
13. Clusterin expression in gastrointestinal neuroendocrine tumours is highly correlated with location and is helpful in determining the origin of liver metastases.
Mourra N; Scriva A; Mansiaux Y; Gozlan S; Bennis M; Balaton A
Histopathology; 2014 Nov; 65(5):642-50. PubMed ID: 24807631
[TBL] [Abstract][Full Text] [Related]
14. Patterns of metastasis in colon and rectal cancer.
Riihimäki M; Hemminki A; Sundquist J; Hemminki K
Sci Rep; 2016 Jul; 6():29765. PubMed ID: 27416752
[TBL] [Abstract][Full Text] [Related]
15. [Neuroendocrine tumours of the GI tract--data from the German NET Registry].
Begum N; Maasberg S; Plöckinger U; Anlauf M; Rinke A; Pöpperl G; Lehnert H; Izbicki JR; Krausch M; Vashist YK; Raffel A; Bürk CG; Hoffmann J; Goretzki P; Pape UF;
Zentralbl Chir; 2014 Jun; 139(3):276-83. PubMed ID: 23042103
[TBL] [Abstract][Full Text] [Related]
16. Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin.
Hermans BCM; de Vos-Geelen J; Derks JL; Latten L; Liem IH; van der Zwan JM; Speel EM; Dercksen MW; Dingemans AC
Neuroendocrinology; 2021; 111(11):1111-1120. PubMed ID: 33227805
[TBL] [Abstract][Full Text] [Related]
17. Site-specific survival rates for cancer of unknown primary according to location of metastases.
Hemminki K; Riihimäki M; Sundquist K; Hemminki A
Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
[TBL] [Abstract][Full Text] [Related]
18. [The clinical characteristic of 43 cases of neuroendocrine tumors with liver metastases].
Li P; Yang XO; Qian JM
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):289-93. PubMed ID: 22781949
[TBL] [Abstract][Full Text] [Related]
19. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.
Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
